Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate

Add time:09/06/2019    Source:sciencedirect.com

Zolpidem tartarate is a non-benzodiazepine, sedative-hypnotic, which finds its major use in various types of insomnia. The present work relates to development of multiparticulate floating drug delivery system based on gas generation technique to prolong the gastric residence time and to increase the overall bioavailability. Modified release dosage form of zolpidem tartarate adapted to release over a predetermined time period, according to biphasic profile of dissolution, where the first phase is immediate release phase for inducing the sleep and the second phase is modified release phase for maintaining the sleep up to 10 h. The system consists of zolpidem tartarate layered pellets coated with effervescent layer and polymeric membrane. The floating ability and in vitro drug release of the system were dependent on amount of the effervescent agent (sodium bicarbonate) layered onto the drug layered pellets, and coating level of the polymeric membrane (Eudragit® NE 30D). The system could float completely within 5 min and maintain the floating over a period of 10 h. The multiparticulate floating delivery system of zolpidem tartarate with rapid floating and modified drug release was obtained.

We also recommend Trading Suppliers and Manufacturers of (S) -1-AMino-1,2,3,4-Tetrahydronaphthalene Tartarate (cas 114352-02-2). Pls Click Website Link as below: cas 114352-02-2 suppliers

Prev:Effect of tartarate and citrate based food additives on the micellar properties of sodium dodecylsulfate for prospective use as food emulsifier
Next:Nanocrystalline indium-based oxides by tartarate precursor route)